Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease.

Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Ginsberg, C. n., Zelnick, L. R., Block, G. A., Chertow, G. M., Chonchol, M. n., Hoofnagle, A. n., Kestenbaum, B. n., de Boer, I. H. 2020

Abstract

Phosphate binders are commonly used in the treatment of patients with hyperphosphatemia. While phosphate binders are used to lower phosphate, the effects of specific phosphate binder types on vitamin D metabolism are unknown.We performed a secondary analysis of the Phosphate Normalization Trial in which patients with moderate to advanced chronic kidney disease were randomized to receive either placebo, sevelamer carbonate, lanthanum carbonate or calcium acetate for 9 months. We evaluated changes in serum concentrations of vitamin D metabolites including 24,25-dihydroxyvitamin D3 [24,25(OH)2D3], 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], the ratio of 24,25(OH)2D3 to 25-hydroxyvitamin D [the vitamin D metabolite ratio (VMR)] and the ratio of serum 1,25(OH)2D to 25-hydroxyvitamin D.Compared with placebo, randomization to the calcium acetate arm was associated with a 0.6?ng/mL (95% CI 0.2, 1) and 13.5?pg/ng (95% CI 5.5, 21.5) increase in 24,25(OH)2D and VMR, respectively, and a 5.2?pg/mL (95% CI 1.1, 9.4) reduction in 1,25(OH)2D. Randomization to sevelamer carbonate was associated with a 0.5?ng/mL (95% CI -0.9, -0.1) and 11.8?pg/ng (95% CI -20, -3.5) reduction in 24,25(OH)2D3 and VMR, respectively. There was no association of the sevelamer arm with the change in 1,25(OH)2D3, and randomization to lanthanum carbonate was not associated with a change in any of the vitamin D metabolites.Administration of different phosphate binders to patients with moderate to severe CKD results in unique changes in vitamin D metabolism.

View details for DOI 10.1093/ndt/gfaa010

View details for PubMedID 32160298